What We're Reading: Page 140
Industry reads hand-picked by our editors
Nov 22, 2021
-
C&EN
C&EN’s 2021 10 Start-Ups to Watch
-
STAT
FDA approves first drug for genetic cause of dwarfism
-
The Wall Street Journal
Novartis Rethinks Sales Strategy for New Cholesterol Drug Launch
-
The Washington Post
Treatments will change the pandemic, but they can’t end it alone
Nov 19, 2021
-
The Hill
CBO: Democrats' package saves about $160B on drug prices
-
Bloomberg
Insurers Balk at Paying for Biogen’s $56,000-a-Year Alzheimer’s Treatment
-
Chemical & Engineering News
Avilar Therapeutics launches with $60 million to degrade extracellular targets
-
Reuters
Wait what? FDA wants 55 years to process FOIA request over vaccine data
Nov 18, 2021
-
Bloomberg
Novartis Has a Big Pile of Cash and Investors Wanting Action
-
Reuters
J&J sees potential for 14 new multibillion-dollar drugs by 2025
-
FierceBiotech
Sanofi inks $270M cancer AI deal with R&D platform developer Owkin
-
The Wall Street Journal
Former Pittsburgh Steel Mill to Become Biomedical-Manufacturing Plant With Mellon Grant
Nov 17, 2021
-
The New York Times
F.D.A. Plans to Authorize Pfizer Boosters for All Adults This Week
-
Reuters
Pfizer CFO D'Amelio to retire after 15 years at company
-
Endpoints News
First interchangeable biosimilar launches in the US with a tiny discount on list price
-
The Wall Street Journal
SEC Investigating Cassava Sciences, Developer of Experimental Alzheimer’s Drug
Nov 16, 2021
Nov 15, 2021
-
Bloomberg
What Is in the Covid Vaccine? Why Pfizer Won’t Share Its Formula
-
The Wall Street Journal
In Elizabeth Holmes Trial, Ex-Theranos Employees Cite Culture of Fear and Isolation
-
MIT Technology Review
An E. coli biocomputer solves a maze by sharing the work
-
FiercePharma
2021's Fiercest Women in Life Sciences
Nov 12, 2021
-
Financial Times
AstraZeneca to take profits from Covid vaccine sales
-
FiercePharma
Lundbeck to cut 300 jobs to fuel CGRP migraine drug growth
-
The Washington Post
Top Biden health officials push to make coronavirus booster shots available to all adults
-
Nature
COVID antiviral pills: what scientists still want to know
Previous
